Thomas Challman
Medical Director Autism & Developmental Medicine Institute · Geisinger Health System
Credentials: · · · · ·
History
- Present
- 2001–2004
- 1997–2001
Neurodevelopmental Disabilities
- 1991–1994
Research
Methylphenidate: its pharmacology and uses
Review · Mayo Clinic Proceedings · 2000 · First of 2 authors · 252 citations
Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence
Review · The Lancet Neurology · 2013 · 247 citations
JAMA Psychiatry · 2015 · 117 citations
11 papers
4 papers
4 papers
- AL
3 papers · 2 as a resident
3 papers
2 papers
- DL
2 papers · 2 as a resident
- IW
2 papers
Clinical trials
- 2014–2015
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
Principal investigator · Completed · Phase 2
Neuren Pharmaceuticals Limited